Chih-Min Kam
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Protease and Inhibitor Mechanisms 8
-
- Blood Coagulation and Thrombosis Mechanisms 4
- Co-authors
- James C. PowersDorothy HudigJózef OleksyszynNorikazu NishinoJudy LiebermanBogdan BoduszekJohn E. KerriganPaul J. Beresford
- Journals
- Journal of Medicinal Chemistry (5 papers)Archives of Biochemistry and Biophysics (4 papers)Biochemistry (4 papers)FEBS Letters (2 papers)Molecular Immunology (2 papers)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Chih-Min Kam
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 231
- Oncology 361
- Immunology 273
- Hematology 127
- Immunology and Allergy 67
Countries citing papers authored by Chih-Min Kam
This map shows the geographic impact of Chih-Min Kam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih-Min Kam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih-Min Kam more than expected).
Fields of papers citing papers by Chih-Min Kam
This network shows the impact of papers produced by Chih-Min Kam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih-Min Kam. The network helps show where Chih-Min Kam may publish in the future.
Co-authors
The 25 scholars most cited alongside Chih-Min Kam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 43 | |
| 2 | 2003 | 14 | |
| 3 | 2002 | 47 | |
| 4 | 2001 | 26 | |
| 5 | 2000 | 121 | |
| 6 | 1999 | 88 | |
| 7 | 1998 | 19 | |
| 8 | 1996 | 13 | |
| 9 | 1995 | 4 | |
| 10 | 1995 | 20 | |
| 11 | 1994 | 48 | |
| 12 | 1994 | 86 | |
| 13 | 1994 | 94 | |
| 14 | 1993 | 11 | |
| 15 | 1993 | 10 | |
| 16 | 1992 | 51 | |
| 17 | 1989 | 20 | |
| 18 | 1989 | 3 | |
| 19 | 1988 | 10 | |
| 20 | 1987 | 32 |
About Chih-Min Kam
Chih-Min Kam is a scholar working on Cancer Research, Hematology, Oncology, Pharmacy and Immunology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (12 papers), Protease and Inhibitor Mechanisms (8 papers), Mast cells and histamine (6 papers), Chemical Synthesis and Analysis (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Click Chemistry and Applications (3 papers), Biochemical and Molecular Research (3 papers) and Pesticide Exposure and Toxicity (3 papers). The work is most often cited by research in Cancer Research (231 citations), Oncology (361 citations), Immunology (273 citations), Hematology (127 citations) and Immunology and Allergy (67 citations). Chih-Min Kam has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include James C. Powers, Dorothy Hudig, Józef Oleksyszyn, Norikazu Nishino, Judy Lieberman, Bogdan Boduszek, John E. Kerrigan, Paul J. Beresford, Kirsten M. Edwards and Joseph A. Trapani. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Biochemistry and Biophysics, Biochemistry, FEBS Letters and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.